Better Health for All.jpg
Better Health for All.jpg

Better Health for All

At Johnson & Johnson, we have made it our business to advance better health. For more than 130 years, we have been committed to improving the health of individuals, families and communities around the world, including the most vulnerable and underserved populations. Today, we continue to invest and collaborate to help solve some of the most complex global health challenges. By harnessing Johnson & Johnson’s breadth, scale and legacy of scientific innovation, we strive to live Our Credo values and change the trajectory of health for humanity.

In this section, we describe a wide range of strategies, approaches and initiatives that the Johnson & Johnson Family of Companies continues to progress in order to deliver Better Health for All around the world, addressing specific healthcare challenges and needs. In this Report, we provide a broad overview of our engagement and activities in each area. We encourage you to visit our website for additional information.

Key Achievements in 2018

  • Made a significant investment to expand the footprint and capabilities of our dedicated Global Public Health organization in Africa with fully operational regional offices, each staffed with local employees.
  • Launched a new program in Rwanda to enable access to modern anti-psychotics for the broad population, and treated the first person with 3-month long-acting paliperidone palmitate.
  • Enabled access to SIRTURO in 114 countries, including all 30 high MDR-TB burden countries, provided access to 75 countries through the bedaquiline donation program, and delivered access to over 82,509 patients between 2012 and 2018.
  • Continued expanding access to proven interventions and developing new, innovative tools to treat and prevent HIV, including positive primary analysis results of the two Phase 3 clinical studies for a novel, long-acting injectable two-drug regimen to treat HIV.

Areas of Opportunity

  • Continue to build capabilities in digital health, focusing on integrated solutions to improve access to medicines.
  • Encourage open, candid and evidence-based multi-stakeholder dialogue to engage the global community on overcoming access challenges, strengthening health systems and outcomes-based financing.
  • Strengthen measurement of health outcomes by continuing to embed monitoring and evaluation across all programs.

You are leaving and entering a third party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties. Continue